Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ERNA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ERNA
Ernexa Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ERNA
Ernexa Therapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ERNA
1
—
Factor
unlisted
customer
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
ERNA
Ernexa Therapeutics Inc.
Change
1.81
▼
−1.09%
Mkt cap
$3.0M
Revenue
$1,000
Q4 FY24
Revenue
$582,000
FY24
LLY
ELI Lilly & Co
Change
1,369.12
▲
+0.32%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
ERNA
Ernexa Therapeutics Inc.
vs
LLY
ELI Lilly & Co
1.81
▼
−1.09%
Price
1,369.12
▲
+0.32%
$3.0M
Mkt cap
$1.2T
Q4 FY24
$1,000
Revenue
$24.4B
Q3 FY26
FY24
$582,000
Revenue
$65.2B
FY25
Change
Change
ERNA
1.81
▼
−1.09%
vs
LLY
1,369.12
▲
+0.32%
Regular session
Nov 6 '26